The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
The efficacy of FLAG regime in refractory and relapse leukemia
Author(s): 
Pages: 91-92,95
Year: Issue:  2
Journal: JOURNAL OF CLINICAL HEMATOLOGY

Keyword:  白血病急性氟达拉滨造血干细胞移植;
Abstract: 目的:观察氟达拉滨(Flud)、阿糖胞苷(Ara-C)及粒细胞集落刺激因子(G-CSF)(FLAG)方案治疗难治、复发性急性白血病(AL)的疗效及不良反应.方法:采用FLAG方案(Flud 50 mg/d,第1~5天,30 min内静脉滴注完毕;Ara-C 2 g/d,第1~5天,滴完Flud 4 h后开始静脉滴注;G-CSF 300 gg/d,皮下注射,第.天开始直至白细胞数>1×lO9/L)治疗8例难治、复发性AL.结果:8例中有4例完全缓解(CR),4例未缓解(NR);中性粒细胞最低时间在用药后4~12 d,持续12~25 d,血小板最低时间在用药后3~10 d,持续14~35 d.结论:FLAG方案治疗难治、复发性AL有较好疗效,为患者进行造血干细胞移植赢得了时机.
Related Articles
loading...